Figure 4.

A. HRMS fragment ion spectrum; B. GC-MS electron ion impact spectrum; C. HPLC-DAD spectrum; D. FT-IR spectrum of the N-piperidinyl etonitazene powder.

A. HRMS fragment ion spectrum; B. GC-MS electron ion impact spectrum; C. HPLC-DAD spectrum; D. FT-IR spectrum of the N-piperidinyl etonitazene powder.